Open-label Extension for Phase 3 Clinical Trials of Simufilam

NCT05575076 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1081

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Alzheimer Disease

Interventions

DRUG: Simufilam

Sponsor

Cassava Sciences, Inc.